#kidney disease

Compared with their HIV-negative peers, HIV-positive individuals have higher rates of treatment for a host of health problems.

Highlights from HIV and hepatitis C research presented at the 2018 Conference on Retroviruses and Opportunistic Infections (CROI) in Boston

Researchers urge clinicians to closely monitor their patients with HIV and chronic kidney disease.

With a grant to follow their large study population through 2021, researchers hope to gain vital new insights about HIV infection.

For people living with HIV, exposure to hepatitis C virus (HCV) is linked to a higher risk of kidney disease and bone disorders.

People with HIV in British Columbia have a shorter life expectancy and spend longer living with illnesses compared with those without HIV.

A hep C cure in those with HIV is tied to a lower rate of death, AIDS-defining illnesses, advanced cirrhosis and liver cancer.

Conditions include kidney disease, diabetes and high blood pressure.

The proportion of those treated for age-related conditions will steadily rise, creating potential conflicts between treatments.

Curing hepatitis C virus (HCV) is associated with a reduced risk of death, kidney disease and diabetes.

Hepatitis C virus doesn’t significantly impact the risk of death unless it occurs along with other severe diseases.

Look out for these typical med side effects and tell your provider about them at once. They’re seldom serious, and most often fixable.

People with HIV who take Viread, Norvir, Reyataz or Norvir-boosted Kaletra are at increasing risk of kidney disease over time.